Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States

American Journal of Kidney Diseases

Volumn 37, Issue 2, 2001, Pages 366-373

  Abbott, Kevin C ^a   Sawyers, Eric S ^a   Oliver III, James D ^a   Ko, Chia W ^a   Kirk, Allan D ^a   Welch, Paul G ^a   Peters, Thomas G ^a   Agodoa, Lawrence Y ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

African American; Cadaveric renal transplantation; Complications; Donor Recipient race matching; Focal segmental glomerulosclerosis (FSGS); Graft loss; Graft survival; Living donor renal transplantation; Pediatric; Recurrent disease; United States Renal Data System (USRDS); White

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; ETHNIC GROUP; FEMALE; FOCAL GLOMERULOSCLEROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; OUTCOMES RESEARCH; RECURRENT DISEASE;

EID: 0035150859     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.21311     Document Type: Article

References (33)

1. Morphological features of primary focal and segmental glomerulosclerosis
2. Improved graft survival after renal transplantation in the United States, 1988 to 1996
3. Recurrent and de novo glomerular disease after renal transplantation: A report from the Renal Allograft Disease Registry (RADR)
4. Prevalence and long-term outcome of glomerulonephritis in renal allografts
5. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis
6. Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study
7. Recurrent focal glomerulosclerosis: Natural history and response to therapy
8. Renal allograft survival according to primary diagnosis: A report of the North American Pediatric Renal Transplant Cooperative Study
9. Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells
10. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys
11. Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis
12. Focal segmental glomerulosclerosis: A need for caution in live-related transplantation
13. Predictive value of race in post-transplantation recurrence of focal segmental glomerulosclerosis in children
14. The familial risk of end-stage renal disease in African Americans
15. Focal segmental glomerulosclerosis in a kidney transplant population: Hereditary and sporadic forms
16. Long-term survival in renal transplant recipients with graft function
17. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection
18. Recurrence of focal segmental glomerulosclerosis in transplant kidneys: Analysis of incidence and risk factors in 59 allografts
19. Excerpts from the USRDS 1999 annual data report
20. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children
21. The racial prevalence of glomerular lesions in nephrotic adults
22. Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis
23. Impact of donor and recipient factors on graft survival after cadaveric renal transplantation: Data from the UNOS/USRDS database
24. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children
25. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for healthy outcomes in caring for ESRD
26. How good are the data? USRDS data validation special study
27. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy
28. "The FSGS factor": Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
29. Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion
30. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis